William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Deep Fission shares rise 15% in Nasdaq trading debut
-
EBI Acquires Xstim, Strengthening Its Market Leadership and Reinforcing its Position as the Only Pure-Play Bone Growth Stimulation Company
-
William Blair Downgrades Simulations Plus (SLP) to Market Perform Following Acquisition
-
Pattern Group prices secondary offering of 8 million shares at $19 each
-
Pattern Announces Pricing of Secondary Offering of Series A Common Stock
-
William Blair Raising Palo Alto Networks (PANW) FY 2026 FCF estimate from $4,017 million to $4,225 million
-
SpaceX vaults past Amazon's market value as options listing fuels surge
-
Truelink Capital Announces Investment in Horwitz, a Leading Provider of MEP Services
-
William Blair Downgrades Payoneer (PAYO) to Market Perform
-
William Blair Downgrades Roku Inc. (ROKU) to Market Perform, Removes from Conviction List
-
American Express to buy Tripadvisor's restaurant booking unit in $700 million deal
-
Abry Partners Closes $780 Million Oversubscribed Continuation Vehicle for Centauri Health Solutions
-
Pattern launches secondary offering of 8 million shares by Knox Lane
-
Pattern Announces Launch of Proposed Secondary Offering of Series A Common Stock
-
Schwab's May activity shows margin loans nearly double
-
Crowe accelerates long-term growth trajectory with investment from KKR
-
SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
-
Digital Asset Raises $355 Million to Accelerate Canton's Role as Onchain Infrastructure for Capital Markets
-
William Blair lowers data center index to 75 on power concerns
-
William Blair on Circle Internet Group (CRCL): 'We encourage investors to build positions amidst a roughly 40% pullback'
-
William Blair Downgrades J.Jill Inc. (JILL) to Market Perform
-
William Blair on Cullinan Oncology Inc. (CGEM): 'We continue to see multiple opportunities for upside to Cullinan shares'
-
JenaValve Appoints Matt Bacso as Chief Financial Officer
-
Form APP ORDR WILLIAM BLAIR FUNDS
-
Form APP NTC WILLIAM BLAIR FUNDS
-
Smith + Howard Announces Significant Investment from TPG
-
Mama's Creations Reports First Quarter Fiscal 2027 Financial Results
-
Mama's Creations Reports First Quarter Fiscal 2027 Financial Results
-
Form 425 WILLIAM BLAIR FUNDS Filed by: William Blair ETF Trust
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Form N-1A William Blair ETF Trust
-
Form N-8A William Blair ETF Trust
-
FDH Aero Enters Next Phase of Growth Through Partnership with Bain Capital and Audax Private Equity
-
William Blair Starts Fervo Energy (FRVO) at Outperform
-
Liftoff closes $502.6 million IPO with full underwriter option exercise
-
Liftoff Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
William Blair sees Blue Origin recovery benefiting ASTS and KRMN stock
-
Lululemon shares drop as forecast cut spotlights challenges for incoming CEO
-
William Blair on Affirm Holdings (AFRM): 'among our best digital finance ideas'
-
William Blair on LPL Financial Holdings (LPLA): 'Organic growth has been weak in recent months'
-
William Blair on Medline Inc (MDLN) Post Conference: 'Management reiterated the most recent FDA warning letter is isolated'
-
William Blair Upgrades Karat Packaging Inc (KRT) to Outperform
-
Liftoff Announces Pricing of Initial Public Offering
-
AEVEX prices public offering of 8 million shares at $27 each
-
AEVEX Corp. Announces Pricing of Public Offering
-
ScottsMiracle-Gro reaffirms 2026 guidance, sets August investor day
-
ScottsMiracle-Gro Reaffirms Fiscal 2026 Guidance, Announces Investor Day Details
-
CopperTech Metals Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'

